期刊
MUCOSAL IMMUNOLOGY
卷 8, 期 1, 页码 80-93出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/mi.2014.44
关键词
-
类别
资金
- National Multiple Sclerosis Society, NIH [R01AI074745, R01DK076616, 1S10RR02829, R01AI080769]
- Crohn's and Colitis Foundation of America
- NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028293, S10RR002829] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074745, R01AI080769] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076616] Funding Source: NIH RePORTER
Microbial metabolites, such as short-chain fatty acids (SCFAs), are highly produced in the intestine and potentially regulate the immune system. We studied the function of SCFAs in the regulation of T-cell differentiation into effector and regulatory Tcells. We report that SCFAs can directly promote T-cell differentiation into Tcells producing interleukin-17 (IL-17), interferon-gamma and/or IL-10 depending on cytokine milieu. This effect of SCFAs on Tcells is independent of GPR41 or GPR43, but dependent on direct histone deacetylase (HDAC) inhibitor activity. Inhibition of HDACs in Tcells by SCFAs increased the acetylation of p70 S6 kinase and phosphorylation rS6, regulating the mTOR pathway required for generation of Th17 (T helper type 17), Th1, and IL-10(+) Tcells. Acetate (C2) administration enhanced the induction of Th1 and Th17 cells during Citrobacter rodentium infection, but decreased anti-CD3-induced inflammation in an IL-10-dependent manner. Our results indicate that SCFAs promote T-cell differentiation into both effector and regulatory Tcells to promote either immunity or immune tolerance depending on immunological milieu.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据